Langham Hall has supported Atlas Health Capital on the successful raise of its debut private equity fund, Atlas Health Fund I (the “fund”), at £400 million. The fund hit its hard cap and was oversubscribed at final close, less than four months after fundraising began.

‍

The fund will focus on buyout opportunities across selected European healthcare markets, including the UK and Ireland, DACH, Benelux and the Nordics, targeting specialist subsectors in MedTech, Niche Pharma and Animal Health. Founded in 2025 by Ben Long, Atlas Health Capital brings together a team with extensive experience across top-performing private equity firms.

‍

Langham Hall is providing fund administration services from its Jersey office and appointed representative (AR) services from its London office, supporting Atlas Health Capital from launch through to closing.

‍

“We are delighted to have supported Atlas Health Capital on the successful close of its debut fund. As a new manager bringing together a highly experienced team, this is an important milestone and one that reflects the continued confidence investors are placing in specialist healthcare strategies. We look forward to supporting the team as they move into their next investment phase.” – Chris Marshall, Partner, Head of Jersey, Langham Hall

‍

Atlas Health Capital was advised by FirstPoint Equity as lead placement agent and Macfarlanes as legal counsel.